Although the combined administration of IVIg and interferon-β-1a is effective in patients with acute inflammatory demyelinating polyneuropathy [3], it is not obvious that this combined therapy is effective in patients with MAG-related neuropathy. This evidence concerns the gene MAG and Guillain-Barre syndrome, familial.